430 related articles for article (PubMed ID: 26892781)
1. The renewed battle against RAS-mutant cancers.
Zhang F; Cheong JK
Cell Mol Life Sci; 2016 May; 73(9):1845-58. PubMed ID: 26892781
[TBL] [Abstract][Full Text] [Related]
2. Targeting the RAS-dependent chemoresistance: The Warburg connection.
Serna-Blasco R; Sanz-Álvarez M; Aguilera Ó; García-Foncillas J
Semin Cancer Biol; 2019 Feb; 54():80-90. PubMed ID: 29432815
[TBL] [Abstract][Full Text] [Related]
3. The impact of oncogenic RAS on redox balance and implications for cancer development.
Lim JKM; Leprivier G
Cell Death Dis; 2019 Dec; 10(12):955. PubMed ID: 31852884
[TBL] [Abstract][Full Text] [Related]
4. Blockade of mutant RAS oncogenic signaling with a special emphasis on KRAS.
Roskoski R
Pharmacol Res; 2021 Oct; 172():105806. PubMed ID: 34450320
[TBL] [Abstract][Full Text] [Related]
5. Not all RAS mutations are equal: A detailed review of the functional diversity of RAS hot spot mutations.
Burge RA; Hobbs GA
Adv Cancer Res; 2022; 153():29-61. PubMed ID: 35101234
[TBL] [Abstract][Full Text] [Related]
6. Emerging strategies to target RAS signaling in human cancer therapy.
Chen K; Zhang Y; Qian L; Wang P
J Hematol Oncol; 2021 Jul; 14(1):116. PubMed ID: 34301278
[TBL] [Abstract][Full Text] [Related]
7. Network analysis of oncogenic Ras activation in cancer.
Stites EC; Trampont PC; Ma Z; Ravichandran KS
Science; 2007 Oct; 318(5849):463-7. PubMed ID: 17947584
[TBL] [Abstract][Full Text] [Related]
8. Allosteric site variants affect GTP hydrolysis on Ras.
Johnson CW; Fetics SK; Davis KP; Rodrigues JA; Mattos C
Protein Sci; 2023 Oct; 32(10):e4767. PubMed ID: 37615343
[TBL] [Abstract][Full Text] [Related]
9. The Role of Wild-Type RAS in Oncogenic RAS Transformation.
Sheffels E; Kortum RL
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33924994
[TBL] [Abstract][Full Text] [Related]
10. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
To MD; Rosario RD; Westcott PM; Banta KL; Balmain A
Oncogene; 2013 Aug; 32(34):4028-33. PubMed ID: 22945650
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.
Sheffels E; Sealover NE; Wang C; Kim DH; Vazirani IA; Lee E; M Terrell E; Morrison DK; Luo J; Kortum RL
Sci Signal; 2018 Sep; 11(546):. PubMed ID: 30181243
[TBL] [Abstract][Full Text] [Related]
12. Ras Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target.
Chen M; Peters A; Huang T; Nan X
Mini Rev Med Chem; 2016; 16(5):391-403. PubMed ID: 26423697
[TBL] [Abstract][Full Text] [Related]
13. Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion.
Quinlan MP; Quatela SE; Philips MR; Settleman J
Mol Cell Biol; 2008 Apr; 28(8):2659-74. PubMed ID: 18268007
[TBL] [Abstract][Full Text] [Related]
14. The RAS-Effector Interaction as a Drug Target.
Keeton AB; Salter EA; Piazza GA
Cancer Res; 2017 Jan; 77(2):221-226. PubMed ID: 28062402
[TBL] [Abstract][Full Text] [Related]
15. Functional diversity in the RAS subfamily of small GTPases.
Bernal Astrain G; Nikolova M; Smith MJ
Biochem Soc Trans; 2022 Apr; 50(2):921-933. PubMed ID: 35356965
[TBL] [Abstract][Full Text] [Related]
16. Ras protein abundance correlates with Ras isoform mutation patterns in cancer.
Hood FE; Sahraoui YM; Jenkins RE; Prior IA
Oncogene; 2023 Apr; 42(15):1224-1232. PubMed ID: 36864243
[TBL] [Abstract][Full Text] [Related]
17. RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.
Fang B
Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):27-38. PubMed ID: 26350096
[TBL] [Abstract][Full Text] [Related]
18. Evaluating The Role Of Nitric Oxide Synthase In Oncogenic Ras-Driven Tumorigenesis.
Counter C
Redox Biol; 2015 Aug; 5():417. PubMed ID: 28162280
[TBL] [Abstract][Full Text] [Related]
19. RAS, wanted dead or alive: Advances in targeting RAS mutant cancers.
Stalnecker CA; Der CJ
Sci Signal; 2020 Mar; 13(624):. PubMed ID: 32209699
[TBL] [Abstract][Full Text] [Related]
20. Guanosine triphosphatase stimulation of oncogenic Ras mutants.
Ahmadian MR; Zor T; Vogt D; Kabsch W; Selinger Z; Wittinghofer A; Scheffzek K
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7065-70. PubMed ID: 10359839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
